In recent years, the trachoma market is anticipated to grow rapidly during the forecast period. Trachoma is an infectious eye illness caused by the bacteria Chlamydia trachomatis, and it is the largest cause of blindness and one of 20 neglected tropical diseases that impact one billion of the world's poorest people, according to the World Health Organization (WHO). Furthermore, according to the World Health Organization (2018), an estimated 89.1 million people have been treated with medicines to eliminate trachoma, boosting the market's revenue growth.
